tafasitamab,lenalidomide
morphosys,incyte
['l-mind', 'in person', 'lymphoma', 'cml', 'dlbcl', 'morphosys']
we re thrilled to be back in person at the 2023 with some of the world s leading #lymphoma experts. don t miss our poster presentations highlighting final five-year results from the l-mind study in patients with #dlbcl. #17icml 
Global commercial-stage biopharmaceutical company driven by our mission: More life for people with cancer. https://t.co/IMbjQ1Ym1Z